Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary R Matyas

Showing results (61-70 of 120) with videos related to

Pageof 12
Sort By:
Clinical and Vaccine Immunology : CVI|November 18, 2011
Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain sporesKristina K Peachman, Qin Li, Gary R Matyas, et al.
Bioconjugate Chemistry|June 2, 2021
Bivalent Conjugate Vaccine Induces Dual Immunogenic Response That Attenuates Heroin and Fentanyl Effects in MiceRodell C Barrientos, Connor Whalen, Oscar B Torres, et al.
RSC Chemical Biology|June 28, 2021
Synthesis and immunological effects of C14-linked 4,5-epoxymorphinan analogues as novel heroin vaccine haptensEugene S Gutman, Thomas C Irvin, J Brian Morgan, et al.
The Journal of Infectious Diseases|June 13, 2018
Liposome-Encapsulated Human Immunodeficiency Virus-1 gp120 Induces Potent V1V2-Specific Antibodies in HumansMangala Rao, Sayali Onkar, Kristina K Peachman, et al.
The Open Vaccine Journal|September 28, 2011
Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in RabbitsQin Li, Kristina K Peachman, Laurie Sower, et al.
Vaccine|April 30, 2013
Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogsGary R Matyas, Alexander V Mayorov, Kenner C Rice, et al.
NPJ Vaccines|December 22, 2017
Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvantOscar B Torres, Gary R Matyas, Mangala Rao, et al.
Vaccine|December 1, 2010
Highly effective generic adjuvant systems for orphan or poverty-related vaccinesMangala Rao, Kristina K Peachman, Qin Li, et al.
Vaccine|March 10, 2017
Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvantsLabdhi Seth, Karen M Bingham Ferlez, Stephen A Kaba, et al.
Analytical and Bioanalytical Chemistry|August 3, 2014
Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccinesOscar B Torres, Rashmi Jalah, Kenner C Rice, et al.
Pageof 12

Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Clinical and Vaccine Immunology : CVI|November 18, 2011
Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain sporesKristina K Peachman, Qin Li, Gary R Matyas, et al.
Bioconjugate Chemistry|June 2, 2021
Bivalent Conjugate Vaccine Induces Dual Immunogenic Response That Attenuates Heroin and Fentanyl Effects in MiceRodell C Barrientos, Connor Whalen, Oscar B Torres, et al.
RSC Chemical Biology|June 28, 2021
Synthesis and immunological effects of C14-linked 4,5-epoxymorphinan analogues as novel heroin vaccine haptensEugene S Gutman, Thomas C Irvin, J Brian Morgan, et al.
The Journal of Infectious Diseases|June 13, 2018
Liposome-Encapsulated Human Immunodeficiency Virus-1 gp120 Induces Potent V1V2-Specific Antibodies in HumansMangala Rao, Sayali Onkar, Kristina K Peachman, et al.
The Open Vaccine Journal|September 28, 2011
Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in RabbitsQin Li, Kristina K Peachman, Laurie Sower, et al.
Vaccine|April 30, 2013
Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogsGary R Matyas, Alexander V Mayorov, Kenner C Rice, et al.
NPJ Vaccines|December 22, 2017
Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvantOscar B Torres, Gary R Matyas, Mangala Rao, et al.
Vaccine|December 1, 2010
Highly effective generic adjuvant systems for orphan or poverty-related vaccinesMangala Rao, Kristina K Peachman, Qin Li, et al.
Vaccine|March 10, 2017
Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvantsLabdhi Seth, Karen M Bingham Ferlez, Stephen A Kaba, et al.
Analytical and Bioanalytical Chemistry|August 3, 2014
Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccinesOscar B Torres, Rashmi Jalah, Kenner C Rice, et al.
Pageof 12